Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Jan;162(1):101-7.e1.
doi: 10.1016/j.jpeds.2012.06.006. Epub 2012 Jul 11.

Glucose control predicts 2-year change in lipid profile in youth with type 1 diabetes

Collaborators, Affiliations

Glucose control predicts 2-year change in lipid profile in youth with type 1 diabetes

David M Maahs et al. J Pediatr. 2013 Jan.

Abstract

Objective: To test the hypothesis that a change in glycated hemoglobin (A1c) over a follow-up interval of approximately 2 years would be associated with concomitant changes in fasting lipids in individuals with type 1 diabetes (T1D).

Study design: All subjects with T1D diagnosed in 2002-2005 in the SEARCH for Diabetes in Youth study with at least 2 study visits ∼12 and ∼24 months after an initial visit were included (age at initial visit, 10.6 ± 4.1 years; 48% female; diabetes duration, 10 ± 7 months; 76% non-Hispanic white; A1c = 7.7% ± 1.4%). Longitudinal mixed models were fit to examine the relationship between change in A1c and change in lipid levels (total cholesterol [TC], high-density lipoprotein-cholesterol [HDL-c], low-density lipoprotein-cholesterol [LDL-c], log triglycerides [TG], and non-HDL-c) with adjustment for possible confounders.

Results: Change in A1c over time was significantly associated with changes in TC, HDL-c, LDL-c, TG, and non-HDL-c over the range of A1c values. For example, for a person with an A1c of 10% and then a 2% decrease in A1c 2 years later (to 8%), the model predicted concomitant changes in TC (-0.29 mmol/L, -11.4 mg/dL), HDL-c (0.03 mmol/L, 1.3 mg/dL), LDL-c (-0.23 mmol/L, -9.0 mg/dL), and non-HDL-c (-0.32 mmol/L, -12.4 mg/dL) and an 8.5% decrease in TG (mmol/L).

Conclusions: Improved glucose control over a 2-year follow-up was associated with a more favorable lipid profile but may be insufficient to normalize lipids in dyslipidemic T1D youth needing to decrease lipids to goal.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Figure 1a: Estimated Total cholesterol resulting from change in A1c after a 24 month interval Figure 1b: Estimated HDL cholesterol resulting from change in A1c after a 24 month interval Figure 1c: Estimated LDL cholesterol resulting from change in A1c after a 24 month interval Figure 1d: Estimated non-HDL cholesterol resulting from change in A1c after a 24 month interval Figure 1e: Estimated Triglycerides resulting from change in A1c after a 24 month interval
Figure 1
Figure 1
Figure 1a: Estimated Total cholesterol resulting from change in A1c after a 24 month interval Figure 1b: Estimated HDL cholesterol resulting from change in A1c after a 24 month interval Figure 1c: Estimated LDL cholesterol resulting from change in A1c after a 24 month interval Figure 1d: Estimated non-HDL cholesterol resulting from change in A1c after a 24 month interval Figure 1e: Estimated Triglycerides resulting from change in A1c after a 24 month interval
Figure 1
Figure 1
Figure 1a: Estimated Total cholesterol resulting from change in A1c after a 24 month interval Figure 1b: Estimated HDL cholesterol resulting from change in A1c after a 24 month interval Figure 1c: Estimated LDL cholesterol resulting from change in A1c after a 24 month interval Figure 1d: Estimated non-HDL cholesterol resulting from change in A1c after a 24 month interval Figure 1e: Estimated Triglycerides resulting from change in A1c after a 24 month interval
Figure 1
Figure 1
Figure 1a: Estimated Total cholesterol resulting from change in A1c after a 24 month interval Figure 1b: Estimated HDL cholesterol resulting from change in A1c after a 24 month interval Figure 1c: Estimated LDL cholesterol resulting from change in A1c after a 24 month interval Figure 1d: Estimated non-HDL cholesterol resulting from change in A1c after a 24 month interval Figure 1e: Estimated Triglycerides resulting from change in A1c after a 24 month interval
Figure 1
Figure 1
Figure 1a: Estimated Total cholesterol resulting from change in A1c after a 24 month interval Figure 1b: Estimated HDL cholesterol resulting from change in A1c after a 24 month interval Figure 1c: Estimated LDL cholesterol resulting from change in A1c after a 24 month interval Figure 1d: Estimated non-HDL cholesterol resulting from change in A1c after a 24 month interval Figure 1e: Estimated Triglycerides resulting from change in A1c after a 24 month interval

References

    1. Maahs DM, Wadwa RP, Bishop F, Daniels SR, Rewers M, Klingensmith GJ. Dyslipidemia in youth with diabetes: to treat or not to treat? J Pediatr. 2008 Oct;153(4):458–65. - PMC - PubMed
    1. McGill HC, Jr, McMahan CA, Malcom GT, Oalmann MC, Strong JP. Effects of serum lipoproteins and smoking on atherosclerosis in young men and women. The PDAY Research Group. Pathobiological Determinants of Atherosclerosis in Youth. Arterioscler Thromb Vasc Biol. 1997 Feb;17(1):95–106. - PubMed
    1. Berenson GS, Srinivasan SR, Bao W, Newman WP, III, Tracy RE, Wattigney WA. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study [see comments] N Engl J Med. 1998 Jun 4;338(23):1650–6. - PubMed
    1. Raitakari OT, Juonala M, Kahonen M, Taittonen L, Laitinen T, Maki-Torkko N, Jarvisalo MJ, Uhari M, Jokinen E, Ronnemaa T, Akerblom HK, Viikari JS. Cardiovascular risk factors in childhood and carotid artery intima-media thickness in adulthood: the Cardiovascular Risk in Young Finns Study. JAMA. 2003 Nov 5;290(17):2277–83. - PubMed
    1. Silverstein J, Klingensmith G, Copeland K, Plotnick L, Kaufman F, Laffel L, Deeb L, Grey M, Anderson B, Holzmeister LA, Clark N. Care of children and adolescents with type 1 diabetes: a statement of the American Diabetes Association. Diab care. 2005 Jan;28(1):186–212. - PubMed

Publication types